Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

NCT02508038 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
Acute Lymphoblastic Leukemia
Hodgkin Lymphoma
Non-Hodgkin Lymphoma
Myelodysplastic Syndrome
Myeloproliferative Syndrome
Rhabdomyosarcoma
Ewing Sarcoma
Primitive Neuroectodermal Tumor
Osteosarcoma
Neuroblastoma

Interventions

PROCEDURE: TCRαβ+/CD19+ depleted Haploidentical HSCT
DRUG: Zoledronate

Sponsor

University of Wisconsin, Madison